• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于全身炎症反应的累积预后评分在接受结直肠癌根治性手术患者中的评估。

Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.

作者信息

Canna K, McMillan D C, McKee R F, McNicol A-M, Horgan P G, McArdle C S

机构信息

University Department of Surgery, Glasgow Royal Infirmary, Alexandra Parade, Glasgow G31 2ER, Scotland, UK.

出版信息

Br J Cancer. 2004 May 4;90(9):1707-9. doi: 10.1038/sj.bjc.6601757.

DOI:10.1038/sj.bjc.6601757
PMID:15150596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409754/
Abstract

The value of combining Dukes' stage and C-reactive protein to form a cumulative prognostic score was assessed in 147 patients undergoing potentially curative resection for colorectal cancer. The cancer-specific survival rates at 3 years for patients with a cumulative prognostic score of 0, 1 and 2 were 100, 77 and 40%, respectively (HR 4.76, 2.78-8.15, P<0.001).

摘要

在147例接受结直肠癌根治性切除术的患者中，评估了将Dukes分期与C反应蛋白相结合以形成累积预后评分的价值。累积预后评分为0、1和2的患者3年癌症特异性生存率分别为100%、77%和40%（风险比4.76，2.78 - 8.15，P<0.001）。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3b/2409754/bf67b1b82b0e/90-6601757f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3b/2409754/bf67b1b82b0e/90-6601757f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3b/2409754/bf67b1b82b0e/90-6601757f1.jpg

相似文献

1
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.基于全身炎症反应的累积预后评分在接受结直肠癌根治性手术患者中的评估。
Br J Cancer. 2004 May 4;90(9):1707-9. doi: 10.1038/sj.bjc.6601757.
2
Systemic inflammatory response predicts survival following curative resection of colorectal cancer.全身炎症反应可预测结肠癌根治性切除术后的生存情况。
Br J Surg. 2003 Feb;90(2):215-9. doi: 10.1002/bjs.4038.
3
The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.接受结直肠癌根治性切除患者的肿瘤增殖活性、全身炎症反应与生存之间的关系。
Colorectal Dis. 2008 Sep;10(7):663-7. doi: 10.1111/j.1463-1318.2007.01416.x. Epub 2007 Nov 12.
4
Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.基于炎症的病理和生化标准对接受结直肠癌潜在根治性切除患者的预后价值比较。
Ann Surg. 2009 May;249(5):788-93. doi: 10.1097/SLA.0b013e3181a3e738.
5
Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.接受结肠癌潜在根治性手术患者的急诊就诊、全身炎症反应与癌症特异性生存之间的关系。
Am J Surg. 2009 Apr;197(4):544-9. doi: 10.1016/j.amjsurg.2007.12.052. Epub 2008 Jul 9.
6
How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.在杜克B期结直肠癌中应检查多少个淋巴结？基于累积生存率的判定。
Hepatogastroenterology. 2005 Nov-Dec;52(66):1703-6.
7
Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.胸苷酸合成酶、二氢嘧啶脱氢酶和胸苷磷酸化酶表达在接受辅助性5-氟尿嘧啶治疗的结直肠癌患者中的预测作用
Oncology. 2006;70(5):366-77. doi: 10.1159/000098110. Epub 2006 Dec 15.
8
Recurrence and survival after potentially curative surgery for colorectal cancer.结直肠癌根治性手术后的复发与生存情况。
N Z Med J. 1999 Jul 9;112(1091):248-50.
9
Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.杜克B期结直肠癌的预后：重新审视贾斯分类法
Eur J Surg. 1999 Jun;165(6):588-92. doi: 10.1080/110241599750006514.
10
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.结直肠癌患者术前而非术后的全身炎症反应与生存率相关。
Br J Surg. 2007 Aug;94(8):1028-32. doi: 10.1002/bjs.5706.

引用本文的文献

1
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis.全身炎症和临床病理特征对恶性胸膜间皮瘤生存的影响：一项多中心分析
Medicina (Kaunas). 2025 Jan 16;61(1):144. doi: 10.3390/medicina61010144.
2
Predictive and Diagnostic Biomarkers of Anastomotic Leakage: A Precision Medicine Approach for Colorectal Cancer Patients.吻合口漏的预测性和诊断性生物标志物：一种针对结直肠癌患者的精准医学方法
J Pers Med. 2021 May 25;11(6):471. doi: 10.3390/jpm11060471.
3
Influence of Conversion and Anastomotic Leakage on Survival in Rectal Cancer Surgery; Retrospective Cross-sectional Study.

本文引用的文献

1
The spread of rectal cancer and its effect on prognosis.直肠癌的扩散及其对预后的影响。
Br J Cancer. 1958 Sep;12(3):309-20. doi: 10.1038/bjc.1958.37.
2
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.基于全身炎症反应的不可切除非小细胞肺癌患者累积预后评分评估
Br J Cancer. 2003 Sep 15;89(6):1028-30. doi: 10.1038/sj.bjc.6601242.
3
Male gender adversely affects survival following surgery for colorectal cancer.男性性别对结直肠癌手术后的生存产生不利影响。
直肠癌手术中转化和吻合口漏对生存的影响：回顾性横断面研究。
J Gastrointest Surg. 2019 Oct;23(10):2007-2018. doi: 10.1007/s11605-018-3931-6. Epub 2018 Sep 5.
4
Microbial markers in colorectal cancer detection and/or prognosis.结直肠癌检测和/或预后的微生物标志物。
World J Gastroenterol. 2018 Jun 14;24(22):2327-2347. doi: 10.3748/wjg.v24.i22.2327.
5
Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy.营养状况在 FOLFOX/FIRI 为基础的化疗时代的影响。
World J Surg Oncol. 2017 Aug 24;15(1):162. doi: 10.1186/s12957-017-1226-0.
6
Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.Tim-3在人类结直肠癌中表达上调，并与肿瘤进展相关。
Mol Med Rep. 2017 Feb;15(2):689-695. doi: 10.3892/mmr.2016.6065. Epub 2016 Dec 22.
7
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.C反应蛋白是成人实体瘤预后、肿瘤复发及治疗反应的重要生物标志物：一项系统评价
PLoS One. 2015 Dec 30;10(12):e0143080. doi: 10.1371/journal.pone.0143080. eCollection 2015.
8
Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review.术前C反应蛋白和中性粒细胞与淋巴细胞比值在可切除胰腺癌中的预后意义：一项系统评价
HPB (Oxford). 2015 Apr;17(4):285-91. doi: 10.1111/hpb.12355. Epub 2014 Nov 27.
9
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.C反应蛋白在接受分子靶向治疗的中危转移性肾细胞癌患者中的预后意义
Oncol Lett. 2014 Aug;8(2):881-885. doi: 10.3892/ol.2014.2207. Epub 2014 Jun 2.
10
Social network ties and inflammation in U.S. adults with cancer.美国成年癌症患者的社交网络关系与炎症
Biodemography Soc Biol. 2014;60(1):21-37. doi: 10.1080/19485565.2014.899452.
Br J Surg. 2003 Jun;90(6):711-5. doi: 10.1002/bjs.4098.
4
Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator.血清C反应蛋白与结直肠癌患者的生存率相关，但不是一个独立的预后指标。
Eur J Gastroenterol Hepatol. 2003 Apr;15(4):369-73. doi: 10.1097/00042737-200304000-00006.
5
Systemic inflammatory response predicts survival following curative resection of colorectal cancer.全身炎症反应可预测结肠癌根治性切除术后的生存情况。
Br J Surg. 2003 Feb;90(2):215-9. doi: 10.1002/bjs.4038.
6
Inflammation and cancer.炎症与癌症。
Nature. 2002;420(6917):860-7. doi: 10.1038/nature01322.
7
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer.结直肠癌患者的急性期蛋白反应、生存率及肿瘤复发情况
Br J Surg. 2001 Feb;88(2):255-60. doi: 10.1046/j.1365-2168.2001.01669.x.
8
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.结直肠癌患者术前血浆纤溶酶原激活物抑制剂-1水平与血清C反应蛋白水平。RANX05结直肠癌研究组。
Ann Surg Oncol. 2000 Sep;7(8):617-23. doi: 10.1007/BF02725342.
9
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.晚期体重减轻的胃肠道癌患者的预后因素。
Nutr Cancer. 2000;37(1):36-40. doi: 10.1207/S15327914NC3701_4.
10
Stimulation of tumour growth by wound-derived growth factors.伤口来源的生长因子对肿瘤生长的刺激作用。
Br J Cancer. 1999 Mar;79(9-10):1392-8. doi: 10.1038/sj.bjc.6690223.